Apollo Global Management reported third quarter 2026 results, highlighted by record quarterly origination of $114 billion and total assets under management reaching approximately $1.07 trillion. The company also declared a quarterly cash dividend of $0.5625 per share payable on November 30, 2026.
Term
Q3 2026
“Our strong third quarter results reflect the flywheel of our model, which starts with originating increasing amounts of good assets. Origination reached a new high of $114 billion in the quarter, and over the last twelve months, activity exceeded $350 billion while our clients entrusted us with $270 billion of inflows. Behind record pipelines and tangible momentum across the business, our core earnings power is growing and poised for a robust close to 2026 with a strong setup for 2027. Our mission remains clear: we are continuing to build a better, faster, stronger Apollo that is well positioned to lead the next generation of financial services.”
Xenia Hotels & Resorts reported third quarter 2026 financial results, significantly exceeding expectations with a 12.5% increase in Same-Property RevPAR and a 26% increase in Adjusted EBITDAre. The company narrowed its net loss to $2.7 million compared to $13.7 million in the prior year period, driven by strong group and corporate transient demand and disciplined expense management.
Term
Q3 2026
“Our third quarter results significantly surpassed our expectations, as strong broad-based group and corporate transient demand coupled with an incremental increase in leisure demand from several large events drove substantial increases in Same-Property RevPAR, Same-Property Total RevPAR and Same-Property Hotel EBITDA compared to the same period last year.”
Marcel Verbaas, Chairman and Chief Executive Officer
Clarivate PLC reported a decrease in total assets from $11,069.4 million at the end of 2025 to $10,368.3 million as of September 30, 2026. The company is currently executing a Value Creation Plan and has classified its Life Sciences & Healthcare business as held for sale, while maintaining a significant long-term debt position of $4,136.8 million.
DuPont reported third quarter 2026 results with net sales of $1.9 billion, up 4% year-over-year, and organic sales growth of 5%. The company exceeded its quarterly guidance and raised its full-year 2026 outlook, driven by strong performance in Healthcare & Water Technologies and Diversified Industrials.
Term
Q3 2026
“We delivered another quarter of consistent, high-quality performance, once again exceeding our financial guidance. Mid-single-digit organic growth, strong operating leverage and disciplined capital allocation drove significant adjusted EPS growth. Additionally, we delivered strong free cash flow performance, with 121% conversion, underscoring the quality of our earnings and effective execution.”
Lori Koch, DuPont Chief Executive Officer
“We are executing from a position of strength and remain focused on unlocking the full potential of our portfolio to deliver sustained long-term value creation.”
Apple Inc. reported a workforce of approximately 167,000 employees as of September 2026 and highlighted risks associated with emerging technologies like AI and machine learning. The company noted significant supply chain concentration in Asia and warned of new U.S. tariffs announced in early 2025 that could impact costs and product availability.
Gartner reported Q3 2026 financial results with revenues of $1.5 billion and a significant increase in net income to $214 million. The company raised its full-year 2026 guidance for revenue, Adjusted EBITDA, and Adjusted EPS following accelerated contract value growth.
Term
Q3 2026
“Contract Value growth accelerated again. Revenues, Adjusted EBITDA excluding divested operation, Adjusted EPS, and free cash flow were ahead of expectations. We repurchased $1.7 billion of stock over the last four quarters, as our capital allocation continues to create value for our shareholders. In addition, we increased our full year Revenues, Adjusted EBITDA excluding divested operation, Adjusted EPS, and free cash flow guidance.”
Gene Hall, Gartner’s Chairman and Chief Executive Officer
Clarivate reported third quarter 2026 results with total revenues of $567.9 million and a net loss of $80.8 million, impacted by a $62.2 million goodwill impairment charge related to the Life Sciences & Healthcare segment. The company completed the divestiture of its Life Sciences & Healthcare segment on October 6, 2026, and updated its full-year 2026 financial outlook to reflect the transaction.
“Third quarter results continued to improve across key metrics, including organic recurring revenue growth and the return to positive ACV growth in the Intellectual Property segment. We also achieved a major milestone with the early close of the Life Sciences & Healthcare segment divestiture, positioning us for enhanced value creation in our two market-leading segments, Academia & Government and Intellectual Property. The growing commercial traction and customer validation from our AI-led innovation within A&G and IP give us confidence in our ability to deliver on our commitments of accelerating sustained organic growth, expanding free cash flow and reducing leverage.”
Matti Shem Tov, Chief Executive Officer
“We are seeing the benefits of disciplined execution across the business, with improving growth trends, strong margins and continued free cash flow generation. Our focus remains on translating organic growth into sustainable earnings and free cash flow, while maintaining a disciplined approach to capital allocation. Looking ahead, we are well positioned to further strengthen our financial profile and enhance our financial flexibility.”
Michael Easton, Executive Vice President and Chief Financial Officer
IDEAYA Biosciences reported Q3 2026 financial results, highlighting the completion of its first NDA submission for darovasertib in metastatic uveal melanoma. The company maintains a strong balance sheet with $1.15 billion in cash and equivalents, providing a projected cash runway into 2030.
Term
Q3 2026
“We are encouraged by the continued momentum at IDEAYA during the third quarter, marked by the successful completion of our first NDA filing for darovasertib in metastatic uveal melanoma. We also provided multiple clinical data updates at ESMO on darovasertib to support its potential as a foundational therapy across the entire uveal melanoma treatment journey as well as updated data from IDE849, our DLL3 TOP1 ADC, in relapsed SCLC and NEC.”
For the nine months ended September 30, 2026, Nuveen Churchill Direct Lending Corp. reported total investment income of $134.3 million and net investment income of $59.0 million. The company's Net Asset Value (NAV) per share decreased to $17.13 from $17.72 at the end of 2025, primarily driven by $30.8 million in total net realized and unrealized losses.
Fusemachines Inc. reported a net loss of $8.34 million for the nine months ended September 30, 2026, compared to a $5.21 million loss in the prior year period. While revenue slightly decreased to $5.52 million, operating expenses surged to $10.93 million, primarily driven by a significant increase in general and administrative costs.
Archrock reported Q3 2026 revenue of $370.8 million and net income of $84.5 million, driven by strong bookings in the Permian Basin and a tight compression market. The company reaffirmed its full-year 2026 Adjusted EBITDA guidance of $865 million to $885 million and declared a quarterly dividend of $0.23 per share.
Term
Q3 2026
“The continued strength and profitability of our business reflect consistent customer demand and a structurally tight compression market. We achieved our strongest bookings quarter since the second quarter of 2023, including strong bookings in the Permian Basin. Rising gas-to-oil ratios and additional takeaway capacity in the basin are supporting sustained compression requirements.”
Brad Childers, Archrock’s President and Chief Executive Officer
“We remain focused on executing our disciplined growth program, deploying horsepower to meet customer demand and delivering the operational reliability our customers expect. With durable natural gas demand supported by long-term growth in LNG exports and power generation, a strong balance sheet and a disciplined, returns-based approach to capital deployment, Archrock is well positioned to invest alongside our customers at attractive returns, generate durable free cash flow and deliver consistent shareholder returns.”
Brad Childers, Archrock’s President and Chief Executive Officer
InMed Pharmaceuticals Inc. reported its financial results for the quarter ended September 30, 2026, highlighting ongoing research and development expenses related to its cannabinoid-based pipeline. The company continues to manage its cash position to fund clinical trials and proprietary manufacturing technology development.
Louisiana-Pacific Corporation reported Q3 2026 financial results featuring record siding net sales of $473 million, a 7% year-over-year increase. Net income rose to $23 million ($0.32 per diluted share) while Adjusted EBITDA remained flat at $82 million. The company provided full-year 2026 consolidated Adjusted EBITDA guidance of $270 million to $280 million.
Term
Q3 2026
“Siding returned to volume growth in the third quarter and set a new record for net sales. LP's expanded distribution network positions SmartSide Trim & Siding for continued growth and share gains.”
CorVel Corporation reported financial results for its second fiscal quarter ended September 30, 2026, with quarterly revenue increasing 11% year-over-year to $267 million. Diluted earnings per share rose 24% to $0.67, driven by strong momentum in workers' compensation and liability businesses and the implementation of new national health plan contracts within its CERIS division.
Viskase Holdings, Inc. reported its financial results for the third quarter of 2026, reflecting stable demand in the global food packaging and casing markets. The company emphasized cost-containment strategies and operational improvements to offset fluctuations in raw material pricing and logistics costs.
Paymentus Holdings, Inc. reported significant growth for the nine months ended September 30, 2026, with revenue increasing to $1.09 billion from $866.0 million in the prior year. Net income from operations nearly doubled to $92.7 million, driven by increased transaction volume and expanded biller and partner relationships.
Douglas Dynamics reported record third-quarter 2026 results with net sales increasing 35% to $218.0 million and net income rising 166% to $21.2 million. The performance was driven by robust pre-season demand in the Work Truck Attachments segment and strong operational execution, leading the company to raise the lower end of its full-year 2026 guidance.
Term
3 months
“The business results our team has delivered through the first nine months of the year is exceptional and demonstrates the earnings power of our business and the effectiveness of the strategic actions we have taken over the past several years.”
Mark Van Genderen, President & CEO
“We are proud of the operational performance from our Attachments team, which responded to the robust demand for our products with a tremendous effort to produce and ship equipment to our dealers.”
Crown Equity Holdings, Inc. filed its quarterly report for the period ended September 30, 2026, detailing its financial performance and operational results. The filing includes consolidated financial statements and management's discussion regarding the company's position in the digital media and advertising markets.
Black Stone Minerals reported third quarter 2026 net income of $52.4 million and Adjusted EBITDA of $104.1 million. Mineral and royalty production increased 6% sequentially to 34.5 MBoe/d, supporting a 9% increase in the quarterly distribution to $0.35 per unit.
“We are pleased with another strong quarter, reflecting increased development activity and higher oil production and revenue. Continued leasing efforts and active portfolio management have helped promote further development of our oil acreage, providing additional cash flow in the current commodity price environment as our natural gas development programs continue to ramp.”
Taylor DeWalch, Co-CEO and President
“The addition of two significant development areas and an associated long-term development program meaningfully expands our Caturus program and the development footprint within Black Stone’s expanded Shelby Trough position.”
Match Group reported net income of $174.4 million for the third quarter of 2026, a slight increase from $160.8 million in the prior year, despite a 2.5% decline in quarterly revenue to $891.2 million. The company significantly improved its operating income through reduced cost of revenue and general and administrative expenses, while continuing to return capital to shareholders via $337 million in treasury stock purchases year-to-date.
Leidos reported third quarter 2026 revenues of $4.6 billion, a 4% increase year-over-year driven by defense tech and air traffic management demand. Net income rose to $413 million with a strong adjusted EBITDA margin of 13.9%, leading the company to raise its full-year 2026 guidance for the third consecutive quarter.
Term
Q3 2026
“Leidos delivered another quarter of strong financial performance, allowing us to enhance our 2026 guidance for the third consecutive quarter. Our sustained momentum reflects the strength of our focused team, united behind our NorthStar 2030 strategy and committed to delivering on our customers’ most critical missions. Looking ahead, we’ll continue to execute our strategy with confidence, invest in differentiated capabilities, and deploy capital strategically to accelerate growth and create enduring value.”
Hartman vREIT XXI, Inc. filed its annual report for the fiscal year ending 2026, detailing its portfolio of commercial real estate assets and operational performance. The report focuses on rental income stability, property management efficiencies, and the company's liquidity position as a non-traded real estate investment trust.
Emergent BioSolutions reported total assets of $995.2 million as of September 30, 2026, a decrease from $1,318.6 million at year-end 2025. The company is navigating significant debt obligations under a new 2026 Term Loan Agreement and is focused on its medical countermeasure (MCM) contracts with the U.S. government and the commercial performance of NARCAN Nasal Spray.
Empire State Realty Trust reported third quarter 2026 financial results, highlighted by Core FFO of $0.20 per share and positive office leasing spreads for the 21st consecutive quarter. The company also completed the $217.5 million sale of 1359 Broadway and repurchased $85.8 million of its common stock.
Boston Scientific reported net sales of $5.138 billion for the third quarter of 2026, a slight increase from $5.065 billion in the prior year period. Net income attributable to common stockholders decreased to $582 million ($0.40 per diluted share) compared to $755 million ($0.51 per diluted share) in Q3 2025, impacted by higher operating expenses and litigation-related charges.
Strategy Inc reported a significant net income of $19.5 billion for the third quarter of 2026, primarily driven by a $20.9 billion gain on digital assets. However, for the nine months ended September 30, 2026, the company recorded a net loss of $1.2 billion as digital asset gains were offset by earlier losses and increased operating expenses.
Diversified Healthcare Trust reported a net loss of $50.2 million for the quarter ended September 30, 2026, an improvement from a $164.0 million loss in the prior year period. Total revenues decreased to $367.7 million from $388.7 million, while the company significantly reduced its interest expense and asset impairment charges compared to 2025.
i-80 Gold Corp. reported its Q3 2026 financial results, highlighting the declaration of maiden mineral reserves at Granite Creek and progress on the Archimedes underground project, which remains on track for production by year-end. The company reported revenue of $14.1 million for the quarter and is advancing its Lone Tree Plant refurbishment on schedule to support a long-term production target of 400,000 to 500,000 gold equivalent ounces by the early 2030s.
“During the third quarter, we continued to advance i-80 Gold's hub-and-spoke mining and processing platform which is expected to improve our cost structure and cash generation, and increase annual production to a target of 150,000 to 200,000 ounces of gold in 2028.”
Richard Young, President & Chief Executive Officer
“Together, these milestones build the foundation for i-80 Gold to deliver substantial long-term value for our shareholders.”
Richard Young, President & Chief Executive Officer
Mistras Group reported revenue of $204.6 million for the third quarter of 2026, a 4.6% increase compared to the prior year. Net income attributable to the company decreased to $6.9 million from $13.1 million in the prior year quarter, primarily due to higher selling, general, and administrative expenses and a $4.3 million transaction-related expense.
For the nine months ended September 30, 2026, i-80 Gold Corp. reported revenues of $109.5 million and a net loss of $179.5 million, significantly higher than the $113.3 million loss in the prior year period. The company significantly strengthened its balance sheet with cash and cash equivalents increasing to $411.4 million, while total liabilities rose to $931.1 million due to increased debt and other liabilities.